USPTO Patents Application 10092769

r Q

ft

PTO/SB/05 (11-00)

^ r+l Approved for use through 10/31/2002. OMB 0651-0032

W U.S. Patent and Trademark Office, U S. DEPARTMENT OF COMMERCE

Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number

Please type a plus sign (+) inside this box

UTILITY
PATENT APPLICATION
TRANSMITTAL

(Only for new nonprovisional applications under 37 CFR 1.53(b))

Attorney Docket No.

28758.65

First Inventor

Title

Khosravi

O4

INSULIN-LIKE GROWTH FACTOR SYSTEM AND
CANCER

Express Mail Label No.

EL 828065737 US

d3

APPLICATION ELEMENTS

See MPEP chapter 600 concerning utility patent application contents.

ADDRESS TO:

Commissioner for Patents
Box Patent Application
Washington, DC 20231

o

Fee Transmittal Form (e.g., PTO/SB/17)

(Submit an original and a duplicate for fee processing)

Applicant claims small entity status.
See 37 CFR 1.27.

36

Specification [Total Pages

(preferred arrangement set forth below)

- Descriptive title of the invention

- Cross Reference to Related Applications

- Statement Regarding Fed sponsored R&D

- Reference to sequence listing, a table,
or a computer program listing appendix

- Background of the Invention

- Brief Summary of the Invention

- Brief Description of the Drawings (if filed)

- Detailed Description

- Claim(s)

- Abstract of the Disclosure

7. CD-ROM or CD-R in duplicate, large table or
Computer Program (Appendix)

8. Nucleotide and/or Amino Acid Sequence Submission
(if applicable, all necessary)

a | | Computer Readable Form (CRF)

b. Specification Sequence Listing on:

CD-ROM or CD-R (2 copies); or
i i. CD paper

c. I I Statements verifying identity of above copies

4. H

Drawing(s) (35 U.S.C. 113) [ Total Sheets |§ I ]

[Total Pages \2 | ]

Oath or Declaration

a. □

b. □

El

Newly executed (original or copy)
Copy from a prior application (37 CFR 1 .63 (d))
(for continuation/divisional with Box 18 completed)

. | | DELETION OF INVENTORY

Signed statement attached deleting inventor(s)
named in the prior application, see 37 CFR
1.63(d)(2) and 1.33(b).

Application Data Sheet. See 37 CFR 1 .76

ACCOMPANYING APPLICATION PARTS

4. El

Assignment Papers (cover sheet & document(s))
37 CFR 3.73(b) Statement FTi Power of
(when there is an assignee) ' — ' Attorney
English Translation Document (if applicable)
Information Disclosure I I Copies of IDS

Statement (IDS)/PTO-1449 1 — 1 Citations
Preliminary Amendment

Return Receipt Postcard (MPEP 503)
(Should be specifically itemized)

Certified Copy of Priority Document(s)
(if foreign priority is claimed)

Request and Certification under 35 U.S.C. 122
(b)(2)(B)(i). Applicant must attach form PTO/SB/35
or its equivalent.

Other: Bc^ress ^

18. If a CONTINUING APPLICATION, check appropriate box, and supply the requisite information below and in a preliminary amendment,
or in an Application Data Sheet under 37 CFR 1. 76:

[X] Continuation Q Divisional Q Continuation-in-part(CIP) of prior application No.: 09 / 484,903

Prior application information: Examiner NlCkol, Gai*y B. Group Art Unit:

For CONTINUATION OR DIVISIONAL APPS only: The entire disclosure of the prior application, from which an oath or declaration is supplied under
Box 5b, is considered a part of the disclosure of the accompanying continuation or divisional application and is hereby incorporated by reference.
The incorporation can only be relied upon when a portion has been inadvertently omitted from the submitted application parts.

19. CORRESPONDENCE ADDRESS

□

Customer Number or Bar Code Label

No. orAttacJt oorcoc* iab^ noiv)

□

Correspondence address below

Name

901 Main Street

Address

Suite 3100

City

Country

Name (Print/Type)

Signature

Haynes & Boone, LLP

Dallas

USA

State

Telephone

Texas

214-651-5058

Zip Code

Fax

75202-3789

214-651-5940

Brian J. Hubb

Registration No, (Attorney/Agent)

45,873

Date

Burc, en Hour Statement: This forrnJ^s^ima^ed^ake 0 2 hours to complete. Time will vary depending upon the needs of the individual case 4\ny comments on
the amount of time you are required to complete this form should be sent to the Chief Information Officer, U.S. Patent and Trademark Office Washington DC
20231. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Assistant Commissioner for Patents, Box Patent Application
Washington, DC 20231.

D-838796.1

PTO/SB/17(10-01)
Approved for use through 10/31/2002. OMB 0651-0032
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995. no persons are required to respond to a collection of information unless it displays a valid OMB control numbe r.

TRANSMITTAL
for FY 2002

Patent fees are subject to annual revision.

TOTAL. AMOUNT OF PAYMENT

($) 793.00

Complete if Known

Application Number

Filing Date

First Named Inventor

Examiner Name

Group Art Unit

Attorney Docket No.

Khosravi

Unknown

28758.65

METHOD OF PAYMENT

FEE CALCULATION (continued)

1.D

The Commissioner is hereby authorized to charge
indi cated fees and credit any overpayments to:
Deposit

Account
Number

Deposit
Account
Name

08-1394

Haynes and Boone, LLP

3. ADDITIONAL FEES

Large Small
Entity Entity
Fee Fee Fee Fee
Code ($) Code ($)

Fee Description

Fee Paid

0 Charge Any Additional Fee Required
Under 37 CFR 1.16 and 1.17

Applicant claims small entity status.
' — ' See 37 CFR 1 27

2. 0 Payment Enclosed:

0 Check □ Credit card Q Money Q other

FEE CALCULATION

1. BASIC FILING FEE

Large Entity Small Entity

Fee Fee
Code ($)

101 740

106 330

107 510

108 740
114 160

Fee Fee Fee Description
Code ($)

201 370

206 165

207 255

208 370
214 80

Utility filing fee
Design filing fee
Plant filing fee
Reissue filing fee
Provisional filing fee

Fee Paid

SUBTOTALS) ($) 370.00

2. EXTRA CLAIM FEES

Fee from

Ext ra Claim s below Fee Paic

391

-20** =

Total Claims
Independent
Claims
Multiple Dependent

Large Entity Small Entity

Fee Fee Fee Fee

Code ($) Code ($)

103 18 203 9
102 84 202 42

104 280 204 140

109 84 209 42

110 18 210 9

iajms frefow, Fee Pan
19] x l 9.00|JT7TiK7

T| -3**= | 6] x l 42.00 1 =|252.QQ

Fee Description

Claims in excess of 20

Independent claims in excess of 3

Multiple dependent claim, if not paid

** Reissue independent claims
over original patent

** Reissue claims in excess of 20
and over original patent

SUBTOTAL (2)

($) 423.00

105

130

205

65

Surcharge - late filing fee or oath

197

227

25

Surcharge - late provisional filing fee or
cover sheet

139

130

139

130

Non-Enghsh specification

147

2,520

147 2,520

For filing a request for ex parte reexaminat

112

920*

112

920*

Requesting publication of SIR prior to
Examiner action

113

1,840*

113 1,840* Requesting publication of SIR after
Examiner action

115

110

215

55

Extension for reply within first month

116

400

216

200

Extension for reply within second month

117

920

217

460

Extension for reply within third month

118

1,440

218

720

Extension for reply within fourth month

128

1,960

228 980

Extension for reply within fifth month

119

320

219

160

Notice of Appeal

120

320

220

160

Filing a brief in support of an appeal

121

280

221

140

Request for oral hearing

138

1,510

1381,510

Petition to institute a public use proceeding

140

110

240

55

Petition to revive - unavoidable

141

1,280

241

640

Petition to revive - unintentional

142

1,280

242

640

Utility issue fee (or reissue)

143

460

243

230

Design issue fee

144

620

244

310

Plant issue fee

122

130

122

130

Petitions to the Commissioner

123

50

123

50

Processing fee under 37 CFR 1.17(q)

126

180

126

180

Submission of Information Disclosure Stmt

581

40

581

40

Recording each patent assignment per
property (times number of properties)

146

740

246

370

Filing a submission after final rejection
(37 CFR § 1.129(a))

149

740

249

370

For each additional invention to be
examined (37 CFR § 1.129(b))

179

740

279

370

Request for Continued Examination (RCE)

169
Other

900 169
fee (specify)

900

Request for expedited examination
of a design application

c *or number previously paid, if greater; For Reissues, see above

*Reduced by Basic Filing Fee Paid

SUBTOTAL (3)

($) 0.00

WARNINGyrffiformation on this form may become public. Credit card information should not

be included on this form. Provide credit card information and authorization on PTO-2038. Customer No.

Burden Hour Statement: This form is estimated to take 0.2 hours to complete. Time will vary depending upon the needs of the individual case. Any comments on

onof^rS ^^eSSS^S^S^^ thiS f0rm $h0uld be sent t0 the Chief ,nformat 'on Officer, U.S. Patent and Trademark Office, Washington, DC
20231. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Assistant Commissioner for Patents, Washington DC 20231

PATENT / DOCKET NO. 28758.65

IN THE UNITED STATES PATENT AND TRADEMARK OFFICE

In re application of:
Khosravi, et al.

§
§
§
§
§
§
§
§
§
§

Serial No.: N/A

Examiner: N/A

Filed: Herewith

Group Art Unit: N/A

For: INSULIN-LIKE GROWTH FACTOR
SYSTEM AND CANCER

EXPRESS MAIL CERTIFICATE

Box Patent Application
Commissioner for Patents
Washington, D.C. 20231

Express Mail Number: EL 828065737 US
Date of Deposit:

I hereby certify that the following attached papers and fee:

1 . Utility Patent Application Transmittal Sheet;

2. Fee Transmittal Sheet (in duplicate);

3 . Application Data Sheet;

4. Copy of Patent Application consisting of 3 1 pages of Specification, 4 pages of Claims and 1
page Abstract of Disclosure;

5. Formal (8) Drawing sheets;

6. Preliminary Amendment;

7. Copy of Declaration;

8. Copy of Power of Attorney;

9 . Copy of Associate Power of Attorney;

10. Copy of Statement Claiming Small Entity Status;

1 1 . Check in the amount of $793 .00

12. Express Mail Certificate; and

13. A Return Postcard

are being deposited with United States Postal Service "Express Mail Post Office to Addressee" to the
Commissioner for Patents, Box Patent Application, Washington, D.C. 20231.

Typed or Printed Name: Sandra Kubin

D-997 169.1